Oral PD-L1 Inhibitor GS-4224 Selectively Engages PD-L1 High Cells and Elicits Pharmacodynamic Responses in Patients with Advanced Solid Tumors
Journal for ImmunoTherapy of Cancer（2024）
Key words
Immune Checkpoint Inhibitors,Therapies,Investigational,Lymphocyte Activation,Programmed Cell Death 1 Receptor,Clinical Trials as Topic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined